# clm_3D04484E2898

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_net_income  
value: 747,700,000 United States dollar  
valid_from: 2016-06-30  
valid_to: 2016-09-30  
published: 2016-07-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_5525F074C916  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly net income: 747,700,000 United States dollar", as of 2016-06-30 (until 2016-09-30). Claim clm_3D04484E2898, https://asof.is/claim/clm_3D04484E2898, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947816000399/0000059478-16-000399-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q2 FY2016, filed 2016-07-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947816000399/0000059478-16-000399-index.htm (primary, SEC EDGAR 10-Q Q2 FY2016, published 2016-07-28)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_net_income | 440,100,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_3D04484E2898](/claim/clm_3D04484E2898.md) | [clm_F4315B9F6A7A](/claim/clm_F4315B9F6A7A.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.